Search

You searched for "palsies"

552 results found

Zoom

5 June 2020 | | EYE - General
One of the side-effects of the coronavirus pandemic is that suddenly everything is now done on Zoom. In case anyone is fortunate enough to have no idea what this is, Zoom is an app that allows virtual meetings to take...

How to get out of chairing Zoom Meetings

1 August 2022 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
One of the biggest changes brought on by far over the past two years is the emergence of Zoom, Teams, or a similar virtual platform for conducting the meetings we all know and love. There are many advantages, and also...

What's trending Feb/Mar 2023

3 February 2023 | | EYE - General
A round-up of the eye related hot topics that have been trending on social media over the last few weeks. #nativity #needleeye Happy New Year! Let’s kick things off with a holiday-related story. Birmingham-based micro-engraver Graham Short engraved by hand...

Just sign here: the intricacies of consent in the post-Montgomery era

1 February 2018 | EYE - General
The consent process is a vital part of the patient pathway and is far more than just getting the patient to sign on the dotted line. In my work in litigation I often see issues around informed consent resulting in...

Celebrating 225 years of seeing ability in parliament

14 November 2024 | charity, patient stories, government, politics, NHS, achievements
This October, the House of Lords provided the venue for charity SeeAbility’s celebration of its 225th-year anniversary, with people it supports, colleagues, volunteers, funders and partners. They were joined by parliamentarians, including the Rt Hon Lord David Blunkett, who sponsored...

The results of the last survey Aug 2019

1 October 2019 | | EYE - Cataract, EYE - Refractive, EYE - General
Thank you once again for participating in the survey. Some fascinating results once again. Almost one in five of us do not cancel cataract surgery on the day if the blood pressure (BP) is high, which I am surprised about....

Diabetic retinopathy screening in Belize: a country’s journey towards reducing blindness from DR

1 February 2019 | | EYE - Vitreo-Retinal, EYE - General
The rise of diabetes mellitus (DM) and its complications is a public health concern in the Caribbean. The Caribbean Diabetic Retinopathy (DR) Programme, managed by the London School of Hygiene & Tropical Medicine (LSHTM) and funded by the Queen Elizabeth...

2030 In Sight: Ending avoidable sight loss

2 August 2024 | EYE - General
Over 2.2 billion people on our planet live with visual impairment or blindness with 1.1 billion unable to access affordable treatment. The 2030 In Sight sector strategy led by the International Agency for the Prevention of Blindness (IAPB) is an...

Initiatives in macular service provision

1 December 2015 | | EYE - Vitreo-Retinal
A report from Monitor in October 2015 identifies good practices that will realise most of the potential productivity gain in elective care available to NHS hospitals. These include: stratifying patients by risk and creating low-complexity pathways for lower-risk patients (tailoring...

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

Has ‘reduce, reuse and recycle’ gone too far?

7 October 2025 | | Sustainability News, environment, climate change, recycling, waste
The past few decades of surgery since the ‘mad cow disease’ have been dominated by a push to switch to disposable instruments. The reason is to prevent cross-contamination and reduce the risk of surgical site infections – especially so with...

NICE approves treatment for cause of sudden sight loss

15 October 2025 | genetics, neuro-ophthalmology, drugs, new treatments, mitochondrial
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...